The Central Role of USP15 in Disease Regulation: From Molecular Mechanisms to Therapeutic Potential

The Central Role of USP15 in Disease Regulation: From Molecular Mechanisms to Therapeutic Potential

The Central Role of USP15 in Disease Regulation: From Molecular Mechanisms to Therapeutic Potential


Published by ANT BIO PTE. LTD.

Concept


USP15 is a 981‑amino acid deubiquitinating enzyme (DUB) belonging to the ubiquitin‑specific protease (USP) family. It governs a wide array of cellular processes by removing ubiquitin chains from target proteins, thereby modulating protein stability, localization, and signaling activity. With a distinctive modular structure, USP15 acts as a master regulator in the TGF‑β pathway, immune homeostasis, neurodegeneration, and cancer progression.

Research Frontiers


Recent advances have established USP15 as a highly dynamic signaling hub. Its catalytic domain adopts a characteristic “thumb‑palm‑finger” fold, while its N‑terminal coiled‑coil motifs mediate key protein–protein interactions. USP15 acts on multiple ubiquitin chain types (K48, K63, K29), with a preference for K63‑linked chains, emphasizing its broad impact on cellular signaling.

Novel findings reveal that USP15 activity is tightly controlled by phosphorylation, acetylation, and subcellular translocation. It shuttles between the cytoplasm, nucleus, and organelles to regulate DNA repair, autophagy, mitochondrial function, and immune signaling. In disease, USP15 drives cancer progression, immune evasion, and neurodegeneration via pathway‑specific mechanisms.

Research Significance


USP15 represents a high‑value therapeutic target due to its central involvement in multiple unmet medical needs:

  • Drives TGF‑β‑driven tumor invasion and immune suppression
  • Modulates NF‑κB and TCR signaling to shape immune responses
  • Regulates mitophagy and tau phosphorylation in Parkinson’s and Alzheimer’s diseases
  • Controls PD‑L1 stability and antigen presentation, making it a promising immunotherapy target
  • Predicts patient survival and therapeutic response in multiple cancer types

As a druggable enzyme, USP15 opens new avenues for treating cancer, neurodegeneration, and inflammatory diseases.

Related Mechanisms and Research Applications


Core Biological Mechanisms


  1. TGF‑β Pathway Regulation

    USP15 stabilizes TβRI by opposing SMAD7‑SMURF2‑mediated degradation, creating a positive feedback loop that amplifies signaling and drives EMT and metastasis.

  2. Immune Modulation

    USP15 promotes NF‑κB signaling and pro‑inflammatory cytokine release. It also stabilizes PD‑L1, leading to immune checkpoint resistance.

  3. Neurological Roles

    USP15 supports Parkin‑mediated mitophagy in Parkinson’s disease but promotes GSK‑3β‑dependent tau hyperphosphorylation in Alzheimer’s disease.

  4. Enzymatic Regulation

    AKT‑mediated phosphorylation activates USP15, while SIRT1‑mediated deacetylation inhibits it, enabling fine‑tuned signal control.


Research Tools Powered by ANT BIO PTE. LTD.


Investigators studying USP15 rely on high‑quality reagents to explore expression, activity, and interactions:

  • USP15‑specific antibodies for WB, IHC, IF, IP, and FCM
  • Recombinant USP15 proteins for enzymatic and inhibitor assays
  • ELISA kits to quantify pathway components
  • General buffers and detection reagents for consistent results

Brand Mission


ANT BIO PTE. LTD. is dedicated to accelerating breakthrough discoveries in deubiquitination, signaling, and disease biology by providing researchers with reliable, high‑performance reagents to advance science toward novel therapies.

Featured Related Products

Product Category Sub-Brand Key Applications
USP15 & phospho-USP15 antibodies Starter WB, IHC, IF, IP, FCM
Recombinant USP15 protein UA Enzyme assays, drug screening
TGF-β / PD-L1 / NF-κB ELISA Kits Absin Pathway activity quantification
HRP / fluorescent secondary antibodies Absin Signal detection
Universal assay buffers & diluents Absin Stable, reproducible assays



ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.